Welcome to our dedicated page for National Health SEC filings (Ticker: NHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
National HealthCare Corporation filings document operating results, dividend actions, governance matters and capital-structure disclosures for a publicly traded senior health care company. The company’s 8-K reports include earnings releases, quarterly common dividend announcements, director appointments and other material-event disclosures, with NHC common stock registered on the NYSE American.
Proxy materials cover annual meeting matters, shareholder voting, board structure and committee governance. The filing record also describes NHC’s skilled nursing, senior living, behavioral health, home care, hospice, pharmacy, rehabilitation and third-party management activities, along with financial reporting topics such as GAAP and non-GAAP results, marketable equity securities and acquired White Oak operations.
National HealthCare Corporation entered into a new Credit Agreement providing a $475.0 million senior unsecured term loan and a $50.0 million senior unsecured revolving credit facility. The term loan is intended to finance part of the purchase price for NHC’s previously announced acquisition of assets and real property from National Health Investors and affiliates.
The company expects to draw the full $475.0 million term loan, and may draw on the revolver at closing, currently anticipated on or around July 1, 2026, in the third quarter of 2026. The facilities mature five years after initial funding, with the term loan amortizing in quarterly installments of about $5.9 million and the revolver requiring interest-only payments.
Interest is based on Term SOFR or a base rate plus a margin that varies with NHC’s consolidated leverage ratio, initially set at Term SOFR + 1.50% or base rate + 0.50%. The agreement replaces NHC’s existing undrawn credit facility and includes customary financial covenants, events of default, and lender remedies. Commitments terminate automatically if the transaction is not completed or funded by August 31, 2026.
NATIONAL HEALTHCARE CORP Senior VP & CIO Ben Anderson Flatt Sr reported compensation-related stock option activity. He exercised 4,000 options at an exercise price of $94.10 per share, receiving the same number of common shares.
The company withheld 2,739 common shares at $196.00 per share to cover the option exercise price and withholding tax obligations. Following these transactions, he directly beneficially owns about 22,636 common shares, and continues to hold stock options linked to 14,000 shares at $157.13 and 9,000 shares at $90.62 with expirations in 2031 and 2030, respectively.
NATIONAL HEALTHCARE CORP director Richard F. LaRoche Jr. reported an open-market sale of 7,500 shares of common stock at $195.1421 per share. After this sale, he directly holds 205,760 common shares, indicating he retains a substantial equity position.
In addition to these shares, he holds multiple option awards covering 7,500 underlying shares each from grants dated 2022 through 2026, with exercise prices ranging from $55.75 to $171.42 and expirations between 2027 and 2031. No derivative options were exercised in this filing.
National Healthcare Corp CEO Stephen Fowler Flatt reported a small insider transaction involving a bona fide gift of 26 shares of Common Stock, leaving him with 66,987 shares held directly. The filing also updates his outstanding stock option awards.
He holds options over 20,000 shares of Common Stock at an exercise price of $157.13 expiring on February 23, 2031, 12,000 shares at $90.62 expiring on February 28, 2030, 5,000 shares at $94.10 expiring on March 5, 2029, and 4,294 shares at $53.94 expiring on March 8, 2028, all held directly.
National Healthcare Corp senior vice president sells shares and reports option holdings. Sr. VP of Operations Timothy J. Shelly reported an open-market sale of 1,853 shares of National Healthcare Corp common stock at an average price of $197.2176 per share, leaving him with 1,294 directly held shares.
He also reported several outstanding stock option awards on common stock, including options covering 14,000 shares at an exercise price of $157.13 expiring in 2031, 7,333 shares at $90.62 expiring in 2030, 5,333 shares at $94.10 expiring in 2029, and 2,400 shares at $53.94 expiring in 2028.
National Healthcare Corp CEO Stephen Fowler Flatt reported routine equity compensation activity. He exercised stock options to acquire a total of 6,000 shares of common stock at exercise prices of $90.62 and $94.10 per share. The company withheld 4,492 shares to pay the option exercise price and related tax obligations, a non‑market transaction. Following these transactions, Flatt beneficially owns 67,013 shares of common stock directly. He also retains unexercised options over 20,000 shares at an exercise price of $157.13 and options over 4,294 shares at $53.94, with expirations extending to 2031.
National Healthcare Corp SVP and CFO Brian F. Kidd exercised stock options and settled related obligations in shares. He exercised derivative securities covering 4,500 shares of common stock through option exercises and had 3,134 shares of common stock withheld by the company to pay the exercise price and tax withholding obligations. These transactions are compensation-related and were granted under the 2020 Omnibus Equity Incentive Plan. Kidd also retains unexercised options linked to 14,000 and 4,147 underlying common shares at exercise prices of $157.13 and $53.94 per share, respectively.
National HealthCare Corporation entered into a Purchase and Sale Agreement for its subsidiary NHC/OP, L.P. to acquire the land, buildings, and related assets of a portfolio of five skilled nursing facilities from National Health Corporation for $50.5 million, subject to adjustments. The facilities are already managed by NHC affiliates, and existing management agreements will terminate at closing. The buyer will post a $750,000 refundable deposit during an inspection period ending by June 16, 2026, and establish a $2.0 million escrow fund for 12 months after closing to cover indemnity claims. Closing is expected in the second quarter of 2026 but depends on financing, regulatory approvals to transfer operating licenses, and other conditions, and either party may terminate if the transaction is not completed within nine months after June 1, 2026.
National HealthCare Corporation reported the results of its Annual Meeting of Shareholders held on May 7, 2026. Shareholders owning 12,216,578 shares of Common Stock were present in person or by proxy, out of 15,599,046 shares outstanding as of the March 13, 2026 record date, so a quorum was established.
Shareholders re-elected Emil E. Hassan, Lisa Piercey, M.D., and William A. Adams as directors for three-year terms. For example, Hassan received 11,653,122 votes for, 544,934 against, and 18,522 abstentions. Shareholders also approved, on an advisory basis, the compensation of the Named Executive Officers, with 11,964,538 votes for, 233,276 against, and 18,764 abstentions.